Natural Gomesin-like Peptides with More Selective Antifungal Activities

<b>Background</b>: Antimicrobial peptides are generally considered promising drug candidates for combating resistant bacterial infections. However, the selectivity of their action may vary significantly. Natural gomesin, isolated from haemocytes of the tarantula <i>Acanthoscurria g...

Full description

Saved in:
Bibliographic Details
Main Authors: Ilia A. Bolosov, Ekaterina I. Finkina, Ivan V. Bogdanov, Victoria N. Safronova, Pavel V. Panteleev, Tatiana V. Ovchinnikova
Format: Article
Language:English
Published: MDPI AG 2024-12-01
Series:Pharmaceutics
Subjects:
Online Access:https://www.mdpi.com/1999-4923/16/12/1606
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850035502675132416
author Ilia A. Bolosov
Ekaterina I. Finkina
Ivan V. Bogdanov
Victoria N. Safronova
Pavel V. Panteleev
Tatiana V. Ovchinnikova
author_facet Ilia A. Bolosov
Ekaterina I. Finkina
Ivan V. Bogdanov
Victoria N. Safronova
Pavel V. Panteleev
Tatiana V. Ovchinnikova
author_sort Ilia A. Bolosov
collection DOAJ
description <b>Background</b>: Antimicrobial peptides are generally considered promising drug candidates for combating resistant bacterial infections. However, the selectivity of their action may vary significantly. Natural gomesin, isolated from haemocytes of the tarantula <i>Acanthoscurria gomesiana</i>, demonstrates a broad spectrum of antimicrobial activities, being the most effective against pathogenic fungi. <b>Methods</b>: Here, we searched for variants of natural gomesin-like peptides and produced their recombinant analogs in the bacterial expression system. The antimicrobial activities of the obtained peptides were tested against a panel of bacterial and yeast strains, and their toxicity towards human cells was examined. <b>Results</b>: Most of the new analogs of gomesin have primary structures homologous to that of the natural gomesin; however, they have fewer amino acid residues and post-translational modifications. One of the discovered analogs, the His-rich shorter peptide from the spider <i>Dysdera sylvatica</i>, designated as DsGom, displays antifungal activity comparable with that of natural gomesin. In the process of the structural–functional study of DsGom, it was shown that this analog retains a basic mechanism of action similar to that of natural gomesin. The DsGom analog has a significantly better toxicity profile as compared to gomesin. At the same time, the loss of the first Arg residue reduces, but does not annul, the antifungal activity of DsGom. Moreover, the acidification of the growth medium reduces the loss of the antifungal activity of this analog. <b>Conclusions</b>: The discovered natural gomesin-like peptides display more selective antifungal activities as compared to gomesin. The low cytotoxicity of DsGom, combined with its high antifungal activity and stability, allows us to consider it a promising drug candidate for the treatment of fungal infections, especially those caused by fungi of the Candida genus.
format Article
id doaj-art-bc3b51bedd994f1ea8db931349b7d4bd
institution DOAJ
issn 1999-4923
language English
publishDate 2024-12-01
publisher MDPI AG
record_format Article
series Pharmaceutics
spelling doaj-art-bc3b51bedd994f1ea8db931349b7d4bd2025-08-20T02:57:28ZengMDPI AGPharmaceutics1999-49232024-12-011612160610.3390/pharmaceutics16121606Natural Gomesin-like Peptides with More Selective Antifungal ActivitiesIlia A. Bolosov0Ekaterina I. Finkina1Ivan V. Bogdanov2Victoria N. Safronova3Pavel V. Panteleev4Tatiana V. Ovchinnikova5M.M. Shemyakin & Yu.A. Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, 117997 Moscow, RussiaM.M. Shemyakin & Yu.A. Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, 117997 Moscow, RussiaM.M. Shemyakin & Yu.A. Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, 117997 Moscow, RussiaM.M. Shemyakin & Yu.A. Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, 117997 Moscow, RussiaM.M. Shemyakin & Yu.A. Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, 117997 Moscow, RussiaM.M. Shemyakin & Yu.A. Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, 117997 Moscow, Russia<b>Background</b>: Antimicrobial peptides are generally considered promising drug candidates for combating resistant bacterial infections. However, the selectivity of their action may vary significantly. Natural gomesin, isolated from haemocytes of the tarantula <i>Acanthoscurria gomesiana</i>, demonstrates a broad spectrum of antimicrobial activities, being the most effective against pathogenic fungi. <b>Methods</b>: Here, we searched for variants of natural gomesin-like peptides and produced their recombinant analogs in the bacterial expression system. The antimicrobial activities of the obtained peptides were tested against a panel of bacterial and yeast strains, and their toxicity towards human cells was examined. <b>Results</b>: Most of the new analogs of gomesin have primary structures homologous to that of the natural gomesin; however, they have fewer amino acid residues and post-translational modifications. One of the discovered analogs, the His-rich shorter peptide from the spider <i>Dysdera sylvatica</i>, designated as DsGom, displays antifungal activity comparable with that of natural gomesin. In the process of the structural–functional study of DsGom, it was shown that this analog retains a basic mechanism of action similar to that of natural gomesin. The DsGom analog has a significantly better toxicity profile as compared to gomesin. At the same time, the loss of the first Arg residue reduces, but does not annul, the antifungal activity of DsGom. Moreover, the acidification of the growth medium reduces the loss of the antifungal activity of this analog. <b>Conclusions</b>: The discovered natural gomesin-like peptides display more selective antifungal activities as compared to gomesin. The low cytotoxicity of DsGom, combined with its high antifungal activity and stability, allows us to consider it a promising drug candidate for the treatment of fungal infections, especially those caused by fungi of the Candida genus.https://www.mdpi.com/1999-4923/16/12/1606antimicrobial peptidegomesindata mining<i>Candida</i>
spellingShingle Ilia A. Bolosov
Ekaterina I. Finkina
Ivan V. Bogdanov
Victoria N. Safronova
Pavel V. Panteleev
Tatiana V. Ovchinnikova
Natural Gomesin-like Peptides with More Selective Antifungal Activities
Pharmaceutics
antimicrobial peptide
gomesin
data mining
<i>Candida</i>
title Natural Gomesin-like Peptides with More Selective Antifungal Activities
title_full Natural Gomesin-like Peptides with More Selective Antifungal Activities
title_fullStr Natural Gomesin-like Peptides with More Selective Antifungal Activities
title_full_unstemmed Natural Gomesin-like Peptides with More Selective Antifungal Activities
title_short Natural Gomesin-like Peptides with More Selective Antifungal Activities
title_sort natural gomesin like peptides with more selective antifungal activities
topic antimicrobial peptide
gomesin
data mining
<i>Candida</i>
url https://www.mdpi.com/1999-4923/16/12/1606
work_keys_str_mv AT iliaabolosov naturalgomesinlikepeptideswithmoreselectiveantifungalactivities
AT ekaterinaifinkina naturalgomesinlikepeptideswithmoreselectiveantifungalactivities
AT ivanvbogdanov naturalgomesinlikepeptideswithmoreselectiveantifungalactivities
AT victoriansafronova naturalgomesinlikepeptideswithmoreselectiveantifungalactivities
AT pavelvpanteleev naturalgomesinlikepeptideswithmoreselectiveantifungalactivities
AT tatianavovchinnikova naturalgomesinlikepeptideswithmoreselectiveantifungalactivities